New treatments with curative intent for metastatic colorectal liver cancer

Bibliography

• PORTE RI, CLAVIEN P-A: Epidemiology and natural history of liver tumors. In: Primary, and Secondary Liver Tumors: Current and Emerging Therapies. P-A Clavien, Y Fong, K Lyerly & A Venook (Eds), Blackwell Science Inc., Cambridge, MA, USA (1999):27–35.
   Google Scholar
• STEELE G JR, RAVIKUMAR TS: Resection of hepatic metastases from colorectal cancer. Ann. Surg. (1989) 210:127–138.
   PubMedGoogle Scholar
• FONG Y, KEMENY N, PATY P et al.: Treatment of colorectal cancer hepatic metastases. Semin. Surg. Oncol (1996) 12:219–252.
   PubMed Web of Science ®Google Scholar
• WANEBO HJ, CHU QD, VEZERIDIS MP et al.: Patient selection for hepatic resection of colorectal metastases. Arch. Surg. (1996) 131:322–329.
   PubMedGoogle Scholar
• FORTNER JG, SILVA JS, GOLBEY RB et al.: Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann. Surg. (1984) 199:306–316.
   PubMed Web of Science ®Google Scholar
• ADSON MA, VAN HEERDEN JA, ADSON MH et al.: Resection of hepatic metastases from colorectal cancer. Arch. Surg. (1984) 119:647–651.
   PubMed Web of Science ®Google Scholar
• FONG Y, COHEN A, FORTNER JG et al.: Liver resection for colorectal metastases.' Clin. Oncol (1997) 15:938–946.
   Web of Science ®Google Scholar
• FONGY, FORTNER J, SUN RL et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. (1999) 230:309–321.
   PubMedGoogle Scholar
• NORDLINGER B, GUIGUET M, VAILLANT JC et al.: Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer (1996) 77:1254–1262.
   Google Scholar
• DIZON DS, KEMENY NE: Intrahepatic arterial infusion of chemotherapy: clinical results. Semin. Oncol (2002) 29:126–135.
   PubMedGoogle Scholar
• JOHNSON P: Systemic chemotherapy of liver tumors. Semin. Surg. Oncol (2000) 19:116–124.
   PubMedGoogle Scholar
• BEERBLOCK K, RINALDI Y, ANDRÈ T et al.: Bimonthly high dose leucovorin and 5-fluorouracil 48 hr continuous infusion in patients with advanced colorectal carcinoma. Cancer (1997) 79:1100–1105.
   PubMed Web of Science ®Google Scholar
• BLIJHAM GH, LABIANCHA R, BLEIBERG H: Should patients with advanced colorectal cancer be treated with chemotherapy ? Eur. J. Cancer (1997) 33:815–824.
   Google Scholar
• NORDIC GASTROINTESTINAL TUMOR ADJUVANT THERAPY GROUP: Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J. Clin. Oncol (1992) 10:904–911.
   PubMed Web of Science ®Google Scholar
• SCHEITHAUER W, ROSEN H, KORNEK GV, SEBESTA C, DEPISCH D: Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br. Med. J. (1993) 306(6880):752–755.
   PubMed Web of Science ®Google Scholar
• DE GRAMONT A, VIGNOUD J, TOURNIGAND C et al.: Oxaliplatin with high dose leucovorin and 5- fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer. Eur. J. Cancer (1997) 33:214–219.
   PubMed Web of Science ®Google Scholar
• ••Interesting response rates using anoxaliplatin-based regimen.
   Google Scholar
• DOUILLARD JY, CUNNINGHAM D, ROTH AD et al.: Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicenter randomised trial. Lancet (2000) 355:1041–1047.
   PubMed Web of Science ®Google Scholar
• SALTZ LB, COX JV, BLANKE C et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl. J. Med. (2000) 343:905–914.
   PubMed Web of Science ®Google Scholar
• ••Large, multi-centre trial showing betterresults when irinotecan is used in conjunction with 5-FU and leucovorin versus irinotecan alone.
   Google Scholar
• LORENZ M, MOLLER H-H, STAIB-SEBLER E et al.: Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastase of colorectal carcinoma. Lang. Arch. Surg. (1999) 384:328–338.
   PubMedGoogle Scholar
• HUGHES K, FOSTER J: The role of adjuvant chemotherapy following curative hepatic resection of colorectal metastases. Proc. Am. Soc. Clin. OncoL (1991) 10:145. Abstract.
   Google Scholar
• LORENZ M, MOLLER, H-H, SCHRAMM H et al.: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann. Surg. (1998) 228:756–762.
   PubMedGoogle Scholar
• KEMENY N, HUANG Y, COHEN AM et al.: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. EngL J. Med. (1999) 341:2039–2048.
   PubMed Web of Science ®Google Scholar
• ••Study indicating locoregional therapy withfluorodeoxyuridine associated with systemic 5-FU may be useful in an adjuvant setting.
   Google Scholar
• KEMENY MM, SUDESHA A, GRAY B et al.: Combined modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J. Clin. Oncol (2002) 20:1499–1505.
   PubMed Web of Science ®Google Scholar
• GIACCHETTI S, ITZHAKI M, GRUIA G et al.: Long term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorourocil, leucovorin, oxaliplatin and surgery. Ann. Oncol (1999) 6:663–669.
   Google Scholar
• ••Example of neoadjuvant therapy usingchronomodulated combination of oxaliplatin, 5-FU and leucovorin.
   Google Scholar
• ADAM R, AVISAR E, ARICHE A et al.: Five year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal (liver) metastases. Ann. Surg. Oncol (2001) 8:347–353.
   PubMed Web of Science ®Google Scholar
• CLAVIEN P-A, SELZNER N, MORSE M et al.: Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery (2002) 131:433–443.
   PubMedGoogle Scholar
• ••Co-author's personal experience using aneoadjuvant fluorodeoxyuridine locoregional therapy.
   Google Scholar
• STRASBERG SM, DEHDASHTI F, SIEGEL BA et al.: Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann. Surg. (2001) 233:293–299.
   PubMed Web of Science ®Google Scholar
• ••Patient pre-selection using FDG-PET mayimprove disease free survival.
   Google Scholar
• BRENNAN MF: PET scanning in malignancy: infant, adolescent or mature citizen? Ann. Surg. (2001) 233:320–321.
   Google Scholar
• AZOULAY D, CASTAING D, SMAIL A et al.: Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann. Stag. (2000) 231:480–486.
   Google Scholar
• ELIAS D, OUELLET JF, DE BAERE T et al.: Preoperative selective portal vein embolization before hepatectomy for liver metastases: long term results and impact on survival. Surgery (2002) 131:294–299.
   Google Scholar
• JARNAGIN WR, FONG Y: Repeat resection for liver tumors. In: Primary, and Secondary Liver Tumors: Current and Emerging Therapies. P-A Clavien, Y Fong, K Lyerly & A Venook (Eds), Blackwell Science Inc., Cambridge, MA, USA (1999):27–35.
   Google Scholar
• NEELEMAN N, ANDERSON R: Repeated liver resection for recurrent liver cancer. Br.j Surg. (1996) 83:893–901.
   PubMedGoogle Scholar
• ADAM R, BISMUTH H, CASTAING D et al.: Repeat hepatectomy for colorectal metastases. Ann. Stag. (1997) 225:51–62.
   Google Scholar
• NEELEMAN N, WOBBEST, JAGER GJ, RUERS TJ: Cryosurgery as a treatment modality for colorectal liver metastases. Hepatogastroenterology (2001) 48:325–329.
   PubMedGoogle Scholar
• CURLEY SA, IZZO F, DELRIO P et al: Radiofrequency ablation of uru-esectable primary and metastatic hepatic malignancies: results in 123 patients. Ann. Surg. (1999): 230:1–8.
   PubMed Web of Science ®Google Scholar
• RUERS T, BLEICHRODT RP: Treatment of liver metastases, an update on the possibilities and results. Ear. Cancer (2002) 38:1023–1033.
   PubMed Web of Science ®Google Scholar
• SEIFERT JK, MORRIS DL: Cryotherapy of the resection edge after liver resection for colorectal cancer metastases. Aus. NZ Surg. (1998) 68:725–728.
   PubMedGoogle Scholar
• SATO T: Locoregional immuno (bio)-therapy for liver metastases. Semin. Oncol (2002) 29:160–167.
   PubMed Web of Science ®Google Scholar
• LYGIDAKIS NJ, STRINGARIS K, KOKINIS et al.: Locoregional chemotherapy versus locoregional combined immuno-chemotherapy for patients with advanced metastatic liver disease of colorectal origin: a prospective randomized study. Hepatogastroenterology (1996) 43:212–220.
   PubMedGoogle Scholar
• LYGIDAKIS NJ, ZIRAS N, PARISSIS Jet al.: Resection versus resection combined with adjuvant pre- and post-operative chemotherapy — immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology (1995) 42:155–161.
   Google Scholar